Learn More
Obesity is associated with induction of the ER (endoplasmic reticulum)-stress response signalling and insulin resistance. PTP1B (protein tyrosine phosphatase 1B) is a major regulator of adiposity and insulin sensitivity. The aim of the present study was to investigate the role of L-PTP1B (liver-specific PTP1B) in chronically HFD (high-fat diet) and(More)
Mobile robot navigation under controlled laboratory conditions is, by now, state of the art and reliably achievable. To transfer navigation mechanisms used in such small-scale environments to applications in untreated, large environments, however, is not trivial, and typically requires modifications to the original navigation mechanism: scaling up is hard.(More)
In this paper we present a landmark based navigation mechanism for a mobile robot. The system uses a self-organising mechanism to map the environment as the robot is led around that environment by an operator. Detected landmarks, and their relative position towards each other, are recorded in a map that can subsequently be used to plan and execute paths(More)
Protein tyrosine phosphatase-1B (PTP1B) negatively regulates insulin and leptin signaling, rendering it an attractive drug target for treatment of obesity-induced insulin resistance. However, some studies suggest caution when targeting macrophage PTP1B, due to its potential anti-inflammatory role. We assessed the role of macrophage PTP1B in inflammation and(More)
BACKGROUND Components of the insulin receptor signaling pathway are probably some of the best studied ones. Even though methods for studying these components are well established, the in vivo effects of different fasting regimens, and the time course of insulin receptor phosphorylation and that of its downstream components in insulin-sensitive peripheral(More)
In this paper we present results of experiments carried out with a route learning system for a mobile robot, conducted in a `real world' environment covering distances of several hundred metres. The system uses no odometry and is based on a self-organising mapbuilding process using perceptual landmarks. A performance metric is deened and used to measure the(More)
Protein tyrosine phosphatase 1B (PTP1B), a key negative regulator of leptin and insulin signaling, is positively correlated with adiposity and contributes to insulin resistance. Global PTP1B deletion improves diet-induced obesity and glucose homeostasis via enhanced leptin signaling in the brain and increased insulin signaling in liver and muscle. However,(More)
The synthetic retinoid, Fenretinide (FEN), inhibits obesity and insulin resistance in mice and is in early clinical trials for treatment of insulin resistance in obese humans. We aimed to determine whether alterations in retinoic acid (RA)-responsive genes contribute to the beneficial effects of FEN. We examined the effect of FEN on 3T3-L1 adipocyte(More)
Protein tyrosine phosphatase 1B (PTP1B) is a key negative regulator of insulin signalling. Hepatic PTP1B deficiency, using the Alb-Cre promoter to drive Ptp1b deletion from birth in mice, improves glucose homeostasis, insulin sensitivity and lipid metabolism. The aim of this study was to investigate the therapeutic potential of decreasing liver PTP1B levels(More)